Physician profile
Gary D Fleischer
NPI 1689762841
$747,159.07
in general payments reported to CMS, 2019-2025
43 companies · $251K in 2025
The $251K reported for 2025 was more than what 97% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $43K · 2021: $4,445 · 2022: $39K · 2023: $44K · 2024: $301K · 2025: $251K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $457K · Consulting Fee: $118K · Travel and Lodging: $14K · Education: $4,978 · Food and Beverage: $1,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $457,100.00 |
| Consulting Fee | $117,500.00 |
| Travel and Lodging | $14,383.62 |
| Education | $4,977.76 |
| Food and Beverage | $1,708.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| L&K Biomed Co. , Ltd. | $461,480.07 | 2023-2025 | Lateral Retractor |
| Aurora Spine, INC. | $181,711.93 | 2019-2025 | Zip |
| L&K Spine INC | $44,576.90 | 2024 | |
| Surgalign Spine Technologies, INC. | $20,838.29 | 2019-2020 | |
| Medyssey USA, INC | $20,400.00 | 2023-2024 | |
| Spineart USA INC | $7,191.18 | 2019-2021 | |
| Nevro Corp. | $6,453.32 | 2020-2024 | Senza |
| Abbott Laboratories | $1,012.92 | 2020-2025 | Eterna, Proclaim, Lamitrode |
| Boston Scientific Corporation | $735.56 | 2021-2023 | |
| Medtronic, INC. | $361.99 | 2021-2025 | Kyphon Express II Kyphopak Tray, Aquamantys(Tm), Plasmablade(Tm) |
| Providence Medical Technology, INC. | $193.93 | 2023-2025 | |
| Ulrich Medical USA, INC. | $170.69 | 2022 | |
| Globus Medical, INC. | $147.93 | 2025 | Senza |
| Stryker Corporation | $143.77 | 2019-2020 | |
| Sonex Health, INC. | $133.66 | 2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $128.31 | 2022 | |
| Depuy Synthes Sales INC. | $120.61 | 2021-2023 | Orthovisc |
| Highridge Medical LLC | $102.02 | 2025 | The Tether |
| Pacira Therapeutics, INC. | $100.60 | 2019 | |
| Innovasis INC | $98.94 | 2020-2021 | |
| Medtronic USA, INC. | $87.91 | 2019-2020 | |
| Djo, LLC | $86.04 | 2020 | |
| Si-Bone, INC. | $77.33 | 2020-2022 | |
| 4web, INC. | $76.96 | 2019 | |
| Nuvasive, INC. | $75.04 | 2019 | |
| Alphatec Spine, INC | $73.76 | 2019 | |
| Arteriocyte Medical Systems, INC. | $71.14 | 2019 | |
| Convatec INC. | $66.47 | 2020 | |
| Zimvie INC. | $51.73 | 2022 | |
| Biocomposites INC | $45.44 | 2025 | Stimulan |
| Orthofix Medical, INC. | $36.30 | 2020 | |
| Spinal Elements, INC. | $36.21 | 2024 | |
| Smith+Nephew, INC. | $35.43 | 2019 | |
| Endo Pharmaceuticals INC. | $34.60 | 2020-2022 | |
| Abbvie INC. | $29.67 | 2025 | |
| Misonix INC | $27.81 | 2019 | |
| Spineology INC. | $27.23 | 2019 | |
| Amgen INC. | $22.42 | 2025 | Krystexxa |
| Bioventus LLC | $21.50 | 2022 | |
| Orthogenrx INC. | $21.41 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $21.13 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.85 | 2020 | |
| Elutia, INC. | $15.07 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Fleischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.